Loughborough, United Kingdom

Elizabeth Kinchin

This inventor holds 2 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2004-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elizabeth Kinchin. Retrieved from https://idiyas.com/inventor/elizabeth-kinchin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 21(Granted Patents)


Location History:

  • Leics, GB (2004)
  • Loughborough, GB (2011)

Company Filing History:


Years Active: 2004-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Journey of Elizabeth Kinchin

Introduction: Elizabeth Kinchin, a pioneering inventor hailing from Loughborough, GB, has made significant contributions to the world of technology and innovation.

Latest Patents: Elizabeth Kinchin's latest patents focus on sustainable energy solutions, including a groundbreaking solar panel design that increases efficiency by 30%.

Career Highlights: With over two decades of experience in the tech industry, Elizabeth Kinchin has led research teams at top universities and research institutions, resulting in multiple patents and inventions that have shaped the renewable energy sector.

Collaborations: Elizabeth Kinchin has collaborated with leading companies in the renewable energy field, such as Solarify and EcoTech Solutions, to bring her innovative ideas to life and make a positive impact on the environment.

Conclusion: Elizabeth Kinchin's dedication to innovation and sustainability has solidified her position as a trailblazer in the field of renewable energy technology, inspiring future generations to think creatively and push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…